Studies have demonstrated that GLP-1s reduce major adverse cardiovascular events and slow progression of kidney disease, transforming these agents from glucose-lowering drugs into cardiorenal-metabolic disease modifiers with expanded addressable populations [1]
Planning to transition from Mounjaro or Tirzepatide
Ozempic, Wegovy, and Mounjaro all belong to a group of injectable medicines
The test ($99 as an add-on assessment or $298 standalone) reveals predispositions in peptide pathway genes relevant to GLP-1 signaling and weight regulation
Improved Digestive Health: Alleviate Gastrointestinal Issues GLP-1 pills, such as Wegovy, Ozempic, and Zepbound, significantly enhance digestive health by effectively alleviating gastrointestinal issues such as bloating, constipation, and discomfort